Abstract
Androgen receptor (AR) signaling pathway is required for both development of normal prostate gland and prostate cancer (PC). Patient with advanced disease are usually treated with androgen deprivation therapy. However, this treatment is only palliative, since a castration-resistant PC (CRPC) usually arises within 2–3 years of treatment. The mechanism by which CRPC develops is yet to be fully understood. However, common alteration in CRPC is the overexpression of the AR. Several studies have addressed the molecular changes occurring in AR overexpressing PC cells. The overexpression of AR enhances the binding of the receptor to chromatin in the presence of low concentrations of androgens. Furthermore, under the same conditions, AR overexpression alters also the dynamics of chromatin binding of the receptor and the binding of basic components of the transcriptional machinery. These changes translate into global epigenetic changes, which deserve more attention. Many studies have found that AR activation in CRPC cell models stimulates a different transcriptional program, which may be influenced by cooperative functions of other transcription factors. Thus, not only a single target gene but also a network of genes could be responsible for the disease progression. In fact, functional studies have shown that androgen-regulated genes, which are overÂexpressed in CRPC, are also likely to be important in PC progression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Huggins C, Hodges CV (1941) Cancer Res 1:293–297
Bélanger B, Bélanger A, Labrie F et al (1989) J Steroid Biochem 32:695–698
Liu J, Albert J, Geller J (1986) Prostate 9:199–205
Titus MA, Schell MJ, Lih FB et al (2005) Clin Cancer Res 11:4653–4657
Mohler JL (2008) Adv Exp Med Biol 617:223–234
Stanbrough M, Bubley GJ, Ross K et al (2006) Cancer Res 66:2815–2825
Mostaghel EA, Page ST, Lin DW et al (2007) Cancer Res 67:5033–5041
Locke JA, Guns ES, Lubik AA et al (2008) Cancer Res 68:6407–6415
Locke JA, Guns ES, Lehman ML (2010) Prostate 70:239–251
de Bono JS, Logothetis CJ, Molina A et al (2011) N Engl J Med 364:1995–2005
Scher HI, Fizazi K, Saad F, et al (2012) N Engl J Med 367:1187–1197
Waltering KK, Urbanucci A, Visakorpi T (2012) Mol Cell Endocrinol 360:38–43
Dehm SM, Schmidt LJ, Heemers HV et al (2008) Cancer Res 68:5469–5477
Hu R, Dunn TA, Wei S et al (2009) Cancer Res 69:16–22
Guo Z, Yang X, Sun F et al (2009) Cancer Res 69:2305–2313
Visakorpi T, Hyytinen E, Koivisto P et al (1995) Nat Genet 9:401–406
Palmberg C, Koivisto P, Kakkola L et al (2000) J Urol 164:1992–1995
Linja MJ, Savinainen KJ, Saramäki OR et al (2001) Cancer Res 61:3550–3555
Edwards J, Krishna NS, Grigor KM et al (2003) Br J Cancer 89:552–556
Chen CD, Welsbie DS, Tran C et al (2004) Nat Med 10:33–39
Tamura K, Furihata M, Tsunoda T (2007) Cancer Res 67:5117–5125
Liu W, Laitinen S, Khan S et al (2009) Nat Med 15:559–565
Taylor BS, Schultz N, Hieronymus H et al (2010) Cancer Cell 18:11–22
Wang LG, Johnson EM, Kinoshita Y et al (2008) Cancer Res 68:2678–2688
Li Y, Wang L, Zhang M et al (2009) Cancer Res 69:3332–3338
Sharma A, Yeow WS, Ertel A et al (2010) J Clin Invest 120:4478–4492
Cai C, He HH, Chen S et al (2011) Cancer Cell 20:457–471
Horoszewicz JS, Leong SS, Chu TM (1980) Prog Clin Biol Res 37:115–132
Korenchuk S, Lehr JE, MClean L et al (2001) In Vivo 15:163–168
Saramäki OR, Harjula AE, Martikainen PM et al (2008) Clin Cancer Res 14:3395–3400
Tomlins SA, Rhodes DR, Perner S et al (2005) Science 310:644–648
Waltering KK, Helenius MA, Sahu B et al (2009) Cancer Res 69:8141–8149
Culig Z, Hoffmann J, Erdel M et al (1999) Br J Cancer 81:242–251
Urbanucci A, Sahu B, Seppälä J et al (2012) Oncogene 31:2153–2163
Chang C, Kokontis J, Liao S (1988) Science 240:324–326
Lubahn DB, Joseph DR, Sar M et al (1988) Mol Endocr 2:1265–1275
Perissi V, Rosenfeld MG (2005) Nat Rev Mol Cell Biol 6:542–554
Kokontis J, Takakura K, Hay N et al (1994) Cancer Res 54:1566–1573
Gregory CW, Johnson RT Jr, Mohler JL et al (2001) Cancer Res 61:2892–2988
Wang Q, Li W, Zhang Y et al (2009) Cell 138:245–256
Gregory CW, Johnson RT Jr et al (2001) J Androl 22:537–548
Massie CE, Lynch A, Ramos-Montoya A et al (2011) EMBO J 30:2719–2033
Prescott J, Jariwala U, Jia L et al (2007) Prostate 67:1371–1383
Zhao JC, Yu J, Runkle C et al (2012) Genome Res 22:322–331
Reyes JC, Barra J, Muchardt C et al (1998) EMBO J 17:6979–6991
Xu J, Qiu Y, DeMayo FJ et al (1998) Science 279:1922–1925
Gehin M, Mark M, Dennefeld C et al (2002) Mol Cell Biol 22:5923–5937
Cheung-Flynn J, Prapapanich V, Cox MB (2005) Mol Endocrinol 19:1654–1666
Yong W, Yang Z, Periyasamy S et al (2007) J Biol Chem 282:5026–5036
Linja MJ, Porkka KP, Kang Z et al (2004) Clin Cancer Res 10:1032–1040
Agoulnik IU, Vaid A, Nakka M et al (2006) Cancer Res 66:10594–10602
Li P, Yu X, Ge K et al (2002) Am J Pathol 161:1467–1474
Mestayer C, Blanchère M, Jaubert F et al (2003) Prostate 56:192–200
Culig Z, Comuzzi B, Steiner H et al (2004) J Steroid Biochem Mol Biol 92:265–271
Comuzzi B, Nemes C, Schmidt S et al (2004) J Pathol 204:159–166
Hu XD, Meng QH, Xu JY et al (2011) Biochem Biophys Res Commun 404:903–909
Ficazzola MA, Fraiman M, Gitlin J et al (2001) Carcinogenesis 22:1271–1279
Jalava SE, Urbanucci A, Latonen L et al. (2012) Oncogene. doi:10.1038/onc.2011.624
Urbanucci A, Waltering KK, Suikki HE et al (2008) BMC Cancer 8:219
Heemers HV, Regan KM, Schmidt LJ et al (2009) Mol Endocrinol 23:572–583
Shah S, Prasad S, Knudsen KE (2012) Cancer Res 72:1248–1259
Wang Q, Li W, Liu XS et al (2007) Mol Cell 27:380–392
Massie CE, Adryan B, Barbosa-Morais NL et al (2007) EMBO Rep 8:871–878
Yu J, Mani RS et al (2010) Cancer Cell 17:443–454
Sahu B, Laakso M, Ovaska K et al (2011) EMBO J 30:3962–3976
Takayama K, Tsutsumi S, Katayama S et al (2011) Oncogene 30:619–630
Pereira de Jésus-Tran K, Côté PL, Cantin L et al (2006) Protein Sci 15:987–999
Isaacs JT, D’Antonio JM, Chen S (2012) Prostate. doi:10.1002/pros.22504
Kang Z, Pirskanen A, Jänne OA et al (2002) J Biol Chem 277:48366–48371
Perissi V, Jepsen K, Glass CK et al (2010) Nat Rev Genet 11:109–123
Urbanucci A, Marttila S, Jänne OA et al (2012) Prostate 72:1223–1232
Welsbie DS, Xu J, Chen Y et al (2009) Cancer Res 69:958–966
Makkonen H, Kauhanen M, Jääskeläinen T et al (2011) Mol Cell Endocrinol 331:57–65
Lupien M, Eeckhoute J, Meyer CA et al (2008) Cell 132:958–970
Wang D, Garcia-Bassets I, Benner C et al (2011) Nature 474:390–394
Nakayama T, Watanabe M, Suzuki H et al (2000) Lab Invest 80:1789–1796
Rahman M, Miyamoto H, Chang C (2004) Clin Cancer Res 10:2208–2219
Chmelar R, Buchanan G, Need EF et al (2006) Int J Cancer 120:719–733
Heemers HV, Tindall DJ (2007) Endocr Rev 28:778–808
Strahl B, Allis C (2000) Nature 403:41–45
Verdone L, Agricola E, Caserta M et al (2006) Brief Funct Genomic Proteomic 5:209–221
Ito T (2007) J Biochem (Tokyo) 141:609–614
Andreu-Vieyra C, Lai J, Berman BP et al (2011) Mol Cell Biol 31:4648–4662
Hurtado A, Holmes KA, Ross-Innes CS et al (2011) Nat Genet 43:27–33
Chuu CP, Kokontis JM, Hiipakka RA et al (2011) J Biomed Sci 18:63
Langenhuijsen JF, Badhauser D, Schaaf B et al (2012) Urol Oncol doi:10.1016/j.urolonc
Mottet N, Van Damme J, Loulidi S et al (2012) BJU Int. doi:10.1111/j.1464-410X.2012.11120.x
Mulholland DJ, Tran LM, Li Y et al (2011) Cancer Cell 19:792–804
Carver BS, Chapinski C, Wongvipat J et al (2011) Cancer Cell 19:575–586
Delmore JE, Issa GC, Lemieux ME et al (2011) Cell 146:904–917
Klein KA, Reiter RE, Redula J et al (1997) Nat Med 3:402–408
Veldscholte J, Ris-Stalpers C, Kuiper GG et al (1990) Biochem Biophys Res Commun 173:534–540
Lee YG, Korenchuk S, Lehr J et al (2001) In Vivo 15:157–162
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Urbanucci, A., Waltering, K.K., Mills, I.G., Visakorpi, T. (2013). The Effect of AR Overexpression on Androgen Signaling in Prostate Cancer. In: Wang, Z. (eds) Androgen-Responsive Genes in Prostate Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6182-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6182-1_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6181-4
Online ISBN: 978-1-4614-6182-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)